OHI Earnings Prediction
The chart below shows how OHI performed 10 days before and after its earnings report, based on data from the past quarters. Typically, OHI sees a -3.14% change in stock price 10 days leading up to the earnings, and a -0.27% change 10 days following the report. On the earnings day itself, the stock moves by +0.76%. This data can give you a slight idea of what to expect for the next quarter's release.
OHI Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
279.32M
16.71%
1.19%
Gross Margin
98.59%
-0.07%
-0.12%
Operating Margin
62.80%
37.90%
-5.02%
Net Margin
41.70%
76.55%
0.17%
EPS
0.39
77.27%
-7.14%
No Data Available
OHI Earnings Analysis
Omega Healthcare Investors Inc Corporation (OHI.N) Earnings Conference Call
Positive
FAD and Leverage Improvement: Fourth quarter FAD was $0.70 per share, reflecting continued revenue and EBITDA growth, allowing leverage to be reduced to below 4.0 times debt to EBITDA.
Fourth Quarter Revenue Increase: Revenue for the fourth quarter increased to $279 million, up from $239 million in the same quarter last year, driven by new investments and operator restructurings.
Fourth Quarter FFO Growth: NAREIT FFO for the fourth quarter was $196 million or $0.68 per share, compared to $129 million or $0.50 per share for the same quarter last year, indicating strong financial performance.
Investment Activity Highlights: In 2024, Omega closed 36 transactions, deploying approximately $1.1 billion in capital, showcasing robust investment activity and market confidence.
EBITDAR Coverage Improvement: The trailing twelve month operator EBITDAR coverage for the core portfolio improved to 1.5x, up from 1.49x, reflecting ongoing operational strength and recovery.
Negative
FAD Dilution Impact: Fourth quarter FAD was $0.7 per share, reflecting a dilution impact from significant share issuances, which may hinder future earnings growth.
Revenue Increase with Instability: Despite a year-over-year revenue increase to $279 million, the growth was partially offset by asset sales, indicating potential instability in revenue streams.
Dilutive Impact on AFFO: The company anticipates a dilutive impact on 2025 AFFO guidance due to the issuance of 11 million shares for $438 million, which could negatively affect per-share earnings.
Rental Income Risks: The ongoing restructuring with operator Lavee, which is still in bankruptcy proceedings, poses risks to rental income stability, with full contractual rent of $3.1 million per month at stake.
G&A Expense Projections: Projected G&A expenses for 2025 are expected to run between $12 million to $14 million, indicating potential pressure on profitability amidst rising operational costs.
OHI FAQs
How does OHI typically perform around its earnings report dates?
Is Omega Healthcare Investors Inc (OHI) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
OHI Earning Call Sentiment
Earnings call transcript: Omega Healthcare Q4 2024 beats revenue forecast
OHI.N
-2.47%Positive
The earnings call highlights strong financial performance with a 16.8% YoY revenue increase and a 52% increase in NAREIT FFO. Management provided optimistic guidance with a narrowed and increased AFFO range. The Q&A session revealed a robust investment pipeline and strong operational metrics. However, there are minor concerns regarding labor challenges and lack of clarity on equity issuance. Overall, the positive financial metrics and optimistic outlook suggest a likely stock price increase in the short term.
